id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3020-0005,FDA,FDA-2019-E-3020,Requirement for Information Letter from U.S. Patent and Trademark Office to Squire Patton Boggs (US) LLP,Other,Letter(s),2024-02-28T05:00:00Z,2024,2,2024-02-28T05:00:00Z,,2024-02-28T21:11:52Z,,0,0,090000648641eae3
FDA-2019-E-3020-0004,FDA,FDA-2019-E-3020,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T21:27:14Z,,0,0,090000648555f8ae
FDA-2019-E-3020-0003,FDA,FDA-2019-E-3020,Letter from FDA CDER to US Patent and Trademark Office,Other,Letter(s),2019-09-13T04:00:00Z,2019,9,2019-09-13T04:00:00Z,,2019-09-13T14:10:23Z,,0,0,0900006483f5740e
FDA-2019-E-3020-0001,FDA,FDA-2019-E-3020,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-06-24T04:00:00Z,2019,6,2019-06-24T04:00:00Z,,2019-06-24T15:07:10Z,,0,0,0900006483d39e0e
FDA-2019-E-3020-0002,FDA,FDA-2019-E-3020,"Patent Extension Application from Squire Patton Boggs (US) LLP (on behalf of Rose U, LLC)",Other,Letter(s),2019-06-24T04:00:00Z,2019,6,2019-06-24T04:00:00Z,,2019-06-24T15:13:57Z,,0,0,0900006483d39e0f